Abstract

2281P Multi-omics evaluation of TFE3-fusions and potential association with immuno-metabolic vulnerabilities in alveolar soft part sarcoma (ASPS) and translocation-positive renal cell carcinoma (tRCC)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma?
Jia Chai ... Linni Fan
Pathology | VOL. 55
Jia Chai, et. al.Jia Chai ... Linni Fan
23 Aug 2022
Alveolar soft part sarcoma and granular cell tumor: an immunohistochemical comparison study.
Benjamin K Chamberlain ... Cheryl M Coffin
Human Pathology | VOL. 45
Benjamin K Chamberlain, et. al.Benjamin K Chamberlain ... Cheryl M Coffin
21 Jan 2014
PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.
Pedram Argani ... Sara E Wobker
The American journal of surgical pathology | VOL. 46
Pedram Argani, et. al.Pedram Argani ... Sara E Wobker
05 Apr 2022
Frequent expression of human leukocyte antigen class I and the status of intratumoral immune cells in alveolar soft part sarcoma.
Akira Ogose ... Hajime Umezu
Oncology letters | VOL. 13
Akira Ogose, et. al.Akira Ogose ... Hajime Umezu
08 Feb 2017
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.
M Ambrosini ... F Pietrantonio
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
M Ambrosini, et. al.M Ambrosini ... F Pietrantonio
03 May 2024
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.
R Dent ... J Cortés
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R Dent, et. al.R Dent ... J Cortés
01 May 2024
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC).
...
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 34
, et. al. ...
01 Oct 2023
Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment.
S.M Tolaney ... P Tarantino
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 34
S.M Tolaney, et. al.S.M Tolaney ... P Tarantino
01 Oct 2023
View more papers